Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Darcie D. Seachrist"'
Autor:
Melyssa S. Roberts, Lindsey J. Anstine, Viviane S. Finke, Benjamin L. Bryson, Bryan M. Webb, Kristen L. Weber-Bonk, Darcie D. Seachrist, Parth R. Majmudar, Ruth A. Keri
Publikováno v:
Breast Cancer Research, Vol 22, Iss 1, Pp 1-14 (2020)
Abstract Background Triple-negative breast cancer (TNBC) is characterized by high rates of recurrence and poor overall survival. This is due, in part, to a deficiency of targeted therapies, making it essential to identify therapeutically targetable d
Externí odkaz:
https://doaj.org/article/0fa5c212148142528a088a4038b52224
Autor:
Darcie D. Seachrist, Steven T. Sizemore, Emhonta Johnson, Fadi W. Abdul-Karim, Kristen L. Weber Bonk, Ruth A. Keri
Publikováno v:
Breast Cancer Research, Vol 19, Iss 1, Pp 1-10 (2017)
Abstract Background Follistatin (FST) is an intrinsic inhibitor of activin, a member of the transforming growth factor-β superfamily of ligands. The prognostic value of FST and its family members, the follistatin-like (FSTL) proteins, have been stud
Externí odkaz:
https://doaj.org/article/e59d047322bc45179367f0b23e5abe7a
Autor:
Lindsey J. Anstine, Parth R. Majmudar, Amy Aponte, Salendra Singh, Ran Zhao, Kristen L. Weber-Bonk, Fadi W. Abdul-Karim, Mitchell Valentine, Darcie D. Seachrist, Katelyn E. Grennel-Nickelson, Leslie Cuellar-Vite, Gina M. Sizemore, Steven T. Sizemore, Bryan M. Webb, Cheryl L. Thompson, Ruth A. Keri
Publikováno v:
Cancer Research. 83:997-1015
Breast cancer subtypes and their phenotypes parallel different stages of the mammary epithelial cell developmental hierarchy. Discovering mechanisms that control lineage identity could provide novel avenues for mitigating disease progression. Here we
Autor:
Ruth A. Keri, Cheryl L. Thompson, Bryan M. Webb, Steven T. Sizemore, Gina M. Sizemore, Leslie Cuellar-Vite, Katelyn E. Grennel-Nickelson, Darcie D. Seachrist, Mitchell Valentine, Fadi W. Abdul-Karim, Kristen L. Weber-Bonk, Ran Zhao, Salendra Singh, Amy Aponte, Parth R. Majmudar, Lindsey J. Anstine
Table S1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4558a831273ccf94e5a7871950320006
https://doi.org/10.1158/0008-5472.22549880
https://doi.org/10.1158/0008-5472.22549880
Autor:
Ruth A. Keri, Cheryl L. Thompson, Bryan M. Webb, Steven T. Sizemore, Gina M. Sizemore, Leslie Cuellar-Vite, Katelyn E. Grennel-Nickelson, Darcie D. Seachrist, Mitchell Valentine, Fadi W. Abdul-Karim, Kristen L. Weber-Bonk, Ran Zhao, Salendra Singh, Amy Aponte, Parth R. Majmudar, Lindsey J. Anstine
Supplemental Figure 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0be0d605fbe9e710232d342d27fb1633
https://doi.org/10.1158/0008-5472.22549925
https://doi.org/10.1158/0008-5472.22549925
Autor:
Ruth A. Keri, Cheryl L. Thompson, Bryan M. Webb, Steven T. Sizemore, Gina M. Sizemore, Leslie Cuellar-Vite, Katelyn E. Grennel-Nickelson, Darcie D. Seachrist, Mitchell Valentine, Fadi W. Abdul-Karim, Kristen L. Weber-Bonk, Ran Zhao, Salendra Singh, Amy Aponte, Parth R. Majmudar, Lindsey J. Anstine
Supplemental Figure 3 Legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4aca0705d21ed8a79476b495a612db1b
https://doi.org/10.1158/0008-5472.22549916
https://doi.org/10.1158/0008-5472.22549916
Autor:
Ruth A. Keri, Matthew K. Summers, Vinay Varadan, Steven T. Sizemore, Salendra Singh, Lindsey J. Anstine, Stefanie Avril, Darcie D. Seachrist, Kristen L. Weber-Bonk, Katrina M. Piemonte, Morgan S. Schrock, Jennifer M. Sahni, Melyssa S. Roberts
LIN9 silencing restores docetaxel sensitivity, unlike silencing of LIN37, another member of the MuvB complex.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40c38a6a6bf4164cc9f873af1921e1ce
https://doi.org/10.1158/0008-5472.22425466.v1
https://doi.org/10.1158/0008-5472.22425466.v1
Supplementary Fig. S5 from Rapamycin inhibits multiple stages of c-Neu/ErbB2–induced tumor progression in a transgenic mouse model of HER2-positive breast cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15bad26032ef078395f7c7d75c21863b
https://doi.org/10.1158/1535-7163.22485827.v1
https://doi.org/10.1158/1535-7163.22485827.v1
Autor:
Ruth A. Keri, Matthew K. Summers, Vinay Varadan, Steven T. Sizemore, Salendra Singh, Lindsey J. Anstine, Stefanie Avril, Darcie D. Seachrist, Kristen L. Weber-Bonk, Katrina M. Piemonte, Morgan S. Schrock, Jennifer M. Sahni, Melyssa S. Roberts
Supplemental figure legends and additional methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12d9726abd7190fe394b0695b31132bb
https://doi.org/10.1158/0008-5472.22425445.v1
https://doi.org/10.1158/0008-5472.22425445.v1
Autor:
Ruth A. Keri, Matthew K. Summers, Vinay Varadan, Steven T. Sizemore, Salendra Singh, Lindsey J. Anstine, Stefanie Avril, Darcie D. Seachrist, Kristen L. Weber-Bonk, Katrina M. Piemonte, Morgan S. Schrock, Jennifer M. Sahni, Melyssa S. Roberts
A significant therapeutic challenge for patients with cancer is resistance to chemotherapies such as taxanes. Overexpression of LIN9, a transcriptional regulator of cell-cycle progression, occurs in 65% of patients with triple-negative breast cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65797457414bba5a1a117f22ebfd53ca
https://doi.org/10.1158/0008-5472.c.6512041
https://doi.org/10.1158/0008-5472.c.6512041